SAS and Posit partner to bring governed open source AI to life sciences

SAS and Posit PBC are partnering to give life sciences organizations more flexibility to use SAS and open source technologies in regulated clinical development. The collaboration will connect SAS Viya and SAS Clinical Acceleration with Posit Workbench, Positron, Posit Connect and Posit Package Manager.
- SAS and Posit are partnering on governed open source technology for life sciences.
- The initial focus is clinical development and regulatory requirements.
- SAS Viya and SAS Clinical Acceleration will connect with Posit tools.
- The planned environment supports SAS, R, Python and SQL workflows.
- Shared customers will help determine which clinical workflows come next.
A connected environment for clinical work
The partnership combines SAS's analytics and governance capabilities with Posit's open source technologies. The companies said the initial focus will be clinical development, where organizations must prepare research for regulatory submission while managing data, statistical computing and software environments.
SAS Clinical Acceleration is built on SAS Viya, SAS's cloud-native data and artificial intelligence platform. It combines a secure clinical data repository, a statistical computing environment and AI-assisted clinical data transformations. Posit's products are intended to extend these capabilities by providing a managed enterprise environment for open source technology.
The companies said the integration will give customers more options for working with SAS and R while meeting regulatory requirements. Posit tools will work directly with SAS Viya, connecting workflows across SAS, R, Python and SQL for data scientists and developers.
Governance for SAS, R and Python workflows
Customers will be able to work in managed, versioned R environments while retaining control over dependencies and interoperability constraints with SAS Clinical Acceleration. Positron and Posit Assistant can be used to develop code, while Posit Package Manager helps maintain consistency and reproducibility across R and Python environments.
The companies also described a workflow in which programmers can write SAS and R code in Positron, with SAS Viya executing SAS code under that programmer's permissions. SAS and Posit said they are working with shared customers to determine which clinical workflows they will support next.
For life sciences teams, the stated aim is to combine the flexibility of open source with the transparency, access controls and governance required for regulated clinical research. Regeneron partner Dilip Raghunathan said the arrangement allows programmers to write both types of code in one session, with their own access rights and AI assistance operating within the same controls.
What the partnership means for life sciences users
The agreement addresses a practical challenge for organizations that use both SAS and open source tools in the same clinical workflow. According to the companies, users can avoid separate workarounds, data copying and redundant access-control management while keeping SAS and open source technologies in a connected environment.
The announcement does not specify a release date for particular integrations or list the clinical workflows that will be supported first. Those decisions are still being developed with shared customers. SAS and Posit experts are scheduled to meet customers at PHUSE EU Connect in Glasgow from 15 to 18 November, with Posit at stand 43 and SAS at stand P3.
PR Newswire: SAS et Posit s'associent pour une IA gouvernée dans les sciences de la vie


